Loading...
Markets are bracing for a cautious open as a massive 20% slide in Hims & Hers (HIMS) and a Micron (MU) supply chain snub rattle investor confidence. While tech futures sag, a vacuum of economic data is allowing corporate earnings and regulatory battles to drive the narrative.
⚠️ Educational Content Only: This is not financial advice. Trading options involves significant risk. Consult a licensed professional before making investment decisions.
Markets are bracing for a cautious open as a massive 20% slide in Hims & Hers (HIMS) and a Micron (MU) supply chain snub rattle investor confidence. While tech futures sag, a vacuum of economic data is allowing corporate earnings and regulatory battles to drive the narrative.
We are entering the 'Valentine’s Day Rally' window (Feb 10–14), historically driven by consumer spend optimism. Traders should look for entry signals tomorrow for a potential short-term bullish swing through the 14th.
A major regulatory shift has sent shockwaves through the telehealth and pharma sectors. Hims & Hers (HIMS) crashed 20% after pulling its $49 compounded weight-loss pill under intense legal pressure from Novo Nordisk (NVO) and FDA scrutiny. This move effectively consolidates Novo Nordisk's market dominance, reflected in its 5.70% pre-market surge. The 'Weight-Loss Wars' have transitioned from a supply struggle to a legal and regulatory moat-building exercise.
The chip sector is facing bearish headwinds as reports suggest Nvidia may exclude Micron (MU) from its initial HBM4 production cycle, favoring Samsung instead. This has triggered a 2.90% slide in MU. However, it's not all gloom in tech; Dynatrace (DT) is up 13% on a fiscal Q3 beat and raised guidance, proving that AI-driven software demand remains a resilient pocket of strength despite hardware supply chain jitters.
Institutional flow is heavily favoring Information Technology (RelVol 2.5) and Industrials, with CARR and AMZN seeing aggressive call sweeps. Conversely, Materials and Financials are showing bearish tilt with call/put ratios sitting at a weak 0.7. Traders should monitor the $280 level on AMZN and the $65 level on CARR as critical stop-sweep zones for current long positions.
Plunging 20% after withdrawing its affordable compounded GLP-1 offering amid regulatory heat.
Surging 13% following a robust earnings beat and upwardly revised full-year AI outlook.
Sliding nearly 3% on reports of losing share in Nvidia’s next-gen HBM chip architecture.
Gaining 6.5% on a high-profile strategic partnership expansion with AWS.
The information provided on this platform is for educational purposes only and should not be considered as financial advice, investment recommendations, or trading signals. Past performance does not guarantee future results. You should conduct your own research and consult with a licensed financial advisor before making any investment decisions. Trading options involves substantial risk of loss.
Data Delayed 15 Minutes.
For Educational Purposes Only.
Not Investment Advice.
© 2026 OptionsIQ. All rights reserved.
⚠️ NOT FINANCIAL ADVICE - For educational purposes only.